David Sokal

David Sokal is a seasoned expert in electrophysiology and neural interfacing, currently serving as the Director of Translational Sciences & Engineering at Galvani Bioelectronics since November 2016. In this role, David manages in-house and collaborative studies focused on optimizing stimulation and blocking parameters for neural architectures and disease models. With a PhD in Biology from the University of Nottingham, where research centered on high-density neuronal recordings for epilepsy treatment, David has held significant positions at GSK and Takeda, emphasizing project leadership and disease area strategy in psychiatry. David's extensive experience spans over two decades and includes roles as Principal Scientist in multiple organizations, where contributions to the electrophysiology discipline have been paramount.